Search Results for 'license'

Contract Service Directory Companies

View All Buyers Guide Companies »

• Regulatory Affairs
  

  FDA’s Interpretation of the “Deemed to be a License” Provision of the Biologics Price Competition an

  A look at how the FDA will administer the transition of NDAs to BLAs

  Keith Webber, Ph.D., Lachman Consultant Services 03.06.19
  

  ---

• Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
  

  Numab & Intarcia Enter License Agreement

  Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders

  03.06.19
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  Haselmeier Acquires Drug Manufacturing License

  Now offers assembly, labeling and packaging services for pharma/biopharma

  02.14.19
  

  ---

• 

  argenx and Halozyme Announce License Agreement

  argenx gains use of Halozyme’s ENHANZE drug delivery technology to develop multiple subcutaneous product formulations for current or future argenx products

  02.04.19
  

  ---

• Breaking News | cGMP Manufacture | Drug Development | Industry News
  

  United Therapeutics Completes Ralinepag License Agreement

  Gains exclusive rights to develop and manufacture Phase III candidate ralinepag for PAH

  01.25.19
  

  ---

• Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
  

  Rigel, Grifols Enter License Agreement

  To commercialize fostamatinib disodium hexahydrate in all potential indications in Europe and Turkey

  01.23.19
  

  ---

• Breaking News | Collaborations & Alliances | Industry News
  

  Recro Pharma Amends IV Meloxicam License Agreement with Alkermes

  Reduces 2019 cash requirements by $30 Million; extends approval milestone payments over seven years

  12.26.18
  

  ---

• Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
  

  Orchard & SIRION Enter License Agreement

  SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™

  12.14.18
  

  ---

• Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Industry News
  

  Orbis, Daré Bioscience Enter License Agreement

  Daré Bioscience can now license worldwide rights to Orbis' long-acting contraceptive products

  03.12.18
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Preclinical Outsourcing
  

  Abzena and OBI Pharma Sign ThioBridge License Agreement

  Master services and clinical supply agreement to enable process development and manufacturing by Abzena

  07.14.17
  

  ---